To test and validate our findings in skin cancer models with a documented and pathophysiologically relevant role for IDO1 and oncogenic GLI expression, we shifted our focus to human melanoma cells with JAK/STAT signaling-dependent expression of IDO1 [16, 18, 31]. This evidence concerns the gene GLI1 and melanoma.